Effects of Selenium on Chronic Kidney Disease: A Mendelian Randomization Study

Nutrients. 2022 Oct 23;14(21):4458. doi: 10.3390/nu14214458.

Abstract

Background: Previous observational studies have shown that there is a controversial association between selenium levels and chronic kidney disease (CKD). Our aim was to assess the causal relationship between selenium levels and CKD using Mendelian randomization (MR) analysis.

Methods: We used the two-sample Mendelian randomization (MR) method to analyze the causal role of selenium levels on CKD risk. The variants associated with selenium levels were extracted from a large genome-wide association study (GWAS) meta-analysis of circulating selenium levels (n = 5477) and toenail selenium levels (n = 4162) in the European population. Outcome data were from the largest GWAS meta-analysis of European-ancestry participants for kidney function to date. Inverse variance weighted (IVW) method was used as the main analysis and a series of sensitivity analyses were carried out to detect potential violations of MR assumptions.

Results: The MR analysis results indicate that the genetically predicted selenium levels were associated with decreased estimated glomerular filtration (eGFR) (effect = -0.0042, 95% confidence interval [CI]: -0.0053-0.0031, p = 2.186 × 10-13) and increased blood urea nitrogen (BUN) (effect = 0.0029, 95% confidence interval [CI]: 0.0006-0.0052, p = 0.0136) with no pleiotropy detected.

Conclusions: The MR study indicated that an increased level of selenium is a causative factor for kidney function impairment.

Keywords: Mendelian randomization analysis; chronic kidney disease; environmental factor; epidemiology; selenium.

Publication types

  • Meta-Analysis

MeSH terms

  • Causality
  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis
  • Polymorphism, Single Nucleotide
  • Renal Insufficiency, Chronic*
  • Selenium*

Substances

  • Selenium